Keysight Technologies (NYSE:KEYS) Updates Q3 2026 Earnings Guidance

Keysight Technologies (NYSE:KEYS) updated its third quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 2.430-2.490 for the period, compared to the consensus earnings per share estimate of 2.090. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.6 billion. Keysight Technologies also updated its FY 2026 guidance to EPS.

Wall Street Analyst Weigh In

KEYS has been the topic of several recent research reports. Citigroup raised their price target on Keysight Technologies from $282.00 to $320.00 and gave the stock a “buy” rating in a research report on Monday, March 23rd. The Goldman Sachs Group increased their price objective on Keysight Technologies from $322.00 to $384.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. UBS Group raised their target price on shares of Keysight Technologies from $230.00 to $340.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. JPMorgan Chase & Co. lifted their target price on shares of Keysight Technologies from $300.00 to $360.00 and gave the stock an “overweight” rating in a research note on Thursday, April 16th. Finally, Robert W. Baird lifted their target price on shares of Keysight Technologies from $310.00 to $375.00 and gave the stock an “outperform” rating in a research note on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $332.42.

Keysight Technologies Price Performance

Shares of Keysight Technologies stock opened at $343.99 on Wednesday. The firm has a market cap of $59.00 billion, a PE ratio of 61.98, a price-to-earnings-growth ratio of 2.47 and a beta of 1.26. Keysight Technologies has a 12-month low of $152.85 and a 12-month high of $370.17. The company has a quick ratio of 2.02, a current ratio of 2.60 and a debt-to-equity ratio of 0.41. The company’s fifty day simple moving average is $317.96 and its two-hundred day simple moving average is $251.73.

Keysight Technologies (NYSE:KEYS) last issued its quarterly earnings data on Tuesday, May 19th. The scientific and technical instruments company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.32 by $0.55. The firm had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.71 billion. Keysight Technologies had a return on equity of 19.26% and a net margin of 16.84%.The business’s quarterly revenue was up 31.5% compared to the same quarter last year. During the same period last year, the company earned $1.70 EPS. Keysight Technologies has set its Q3 2026 guidance at 2.430-2.490 EPS. As a group, equities analysts expect that Keysight Technologies will post 7.91 EPS for the current year.

Insider Transactions at Keysight Technologies

In other news, SVP Jeffrey K. Li sold 2,000 shares of Keysight Technologies stock in a transaction that occurred on Tuesday, March 24th. The stock was sold at an average price of $297.19, for a total value of $594,380.00. Following the sale, the senior vice president directly owned 34,499 shares in the company, valued at approximately $10,252,757.81. This trade represents a 5.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronald S. Nersesian sold 30,000 shares of Keysight Technologies stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $285.96, for a total value of $8,578,800.00. Following the completion of the sale, the director owned 163,377 shares in the company, valued at approximately $46,719,286.92. This represents a 15.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 40,334 shares of company stock worth $11,533,230. Corporate insiders own 0.40% of the company’s stock.

Key Keysight Technologies News

Here are the key news stories impacting Keysight Technologies this week:

• Positive Sentiment: Keysight reported record second-quarter results, with EPS of $2.87 versus the $2.32 consensus and revenue of $1.72 billion slightly ahead of expectations. The company said the quarter marked all-time highs in orders, revenue, EPS, and free cash flow. Business Wire earnings release
• Positive Sentiment: Management raised full-year and Q3 outlooks, with Q3 EPS guidance of $2.43-$2.49 and revenue guidance of $1.7 billion-$1.8 billion, both above Wall Street estimates. The company also lifted FY2026 revenue guidance to $6.8 billion-$6.9 billion, signaling confidence in continued momentum. MarketWatch outlook article
• Positive Sentiment: Several reports highlighted strong investor reaction to the “beat-and-raise” quarter, with commentary pointing to surging orders and a powerful AI infrastructure tailwind. Barron’s article
• Positive Sentiment: Analysts also turned more constructive, including Susquehanna lifting its price target to $415 and maintaining a positive view, reinforcing the bullish post-earnings narrative. American Banking News note
• Neutral Sentiment: Keysight’s earnings call transcript and related coverage suggest the company is benefiting from AI-wave demand, but these articles mainly expand on the same earnings story rather than adding new material information. Seeking Alpha transcript

Institutional Investors Weigh In On Keysight Technologies

Large investors have recently made changes to their positions in the business. AQR Capital Management LLC boosted its position in shares of Keysight Technologies by 92.6% during the first quarter. AQR Capital Management LLC now owns 27,216 shares of the scientific and technical instruments company’s stock valued at $3,965,000 after purchasing an additional 13,085 shares in the last quarter. Integrated Wealth Concepts LLC boosted its position in shares of Keysight Technologies by 5.0% during the first quarter. Integrated Wealth Concepts LLC now owns 2,581 shares of the scientific and technical instruments company’s stock valued at $387,000 after purchasing an additional 122 shares in the last quarter. Empowered Funds LLC boosted its position in shares of Keysight Technologies by 30.0% during the first quarter. Empowered Funds LLC now owns 10,652 shares of the scientific and technical instruments company’s stock valued at $1,595,000 after purchasing an additional 2,461 shares in the last quarter. Geneos Wealth Management Inc. boosted its position in shares of Keysight Technologies by 66.5% during the first quarter. Geneos Wealth Management Inc. now owns 393 shares of the scientific and technical instruments company’s stock valued at $59,000 after purchasing an additional 157 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in shares of Keysight Technologies during the second quarter valued at approximately $254,000. 84.58% of the stock is currently owned by institutional investors.

Keysight Technologies Company Profile

Keysight Technologies is a global provider of electronic design, test, measurement and optimization solutions for communications, electronics and related industries. The company was formed as a corporate spin-off from Agilent Technologies in 2014; its origins trace back to the electronic measurement business that was part of Hewlett?Packard before Agilent. Keysight develops hardware and software used throughout the product development lifecycle, from design and simulation to prototype validation and manufacturing test.

Keysight’s product portfolio includes electronic test and measurement instruments such as oscilloscopes, network and spectrum analyzers, signal generators, vector network analyzers and modular PXI-based systems, together with software platforms for simulation, automated test and data analysis.